Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Equity Income (2018 - 2022)

Historic Equity Income for Arcturus Therapeutics Holdings (ARCT) over the last 5 years, with Q2 2022 value amounting to -$131000.0.

  • Arcturus Therapeutics Holdings' Equity Income rose 6006.1% to -$131000.0 in Q2 2022 from the same period last year, while for Dec 2022 it was -$515000.0, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of -$515000.0 for FY2022, which is 20000.0% down from last year.
  • According to the latest figures from Q2 2022, Arcturus Therapeutics Holdings' Equity Income is -$131000.0, which was up 6006.1% from -$384000.0 recorded in Q1 2022.
  • Arcturus Therapeutics Holdings' Equity Income's 5-year high stood at $1.2 million during Q1 2021, with a 5-year trough of -$384000.0 in Q1 2022.
  • Its 5-year average for Equity Income is -$46000.0, with a median of -$143000.0 in 2021.
  • Examining YoY changes over the last 5 years, Arcturus Therapeutics Holdings' Equity Income showed a top increase of 86564.42% in 2021 and a maximum decrease of 22800.0% in 2021.
  • Arcturus Therapeutics Holdings' Equity Income (Quarter) stood at -$255000.0 in 2018, then surged by 81.57% to -$47000.0 in 2019, then tumbled by 112.77% to -$100000.0 in 2020, then crashed by 55.0% to -$155000.0 in 2021, then grew by 15.48% to -$131000.0 in 2022.
  • Its last three reported values are -$131000.0 in Q2 2022, -$384000.0 for Q1 2022, and -$155000.0 during Q4 2021.